loadpatents
name:-0.0071201324462891
name:-0.002500057220459
name:-0.00046896934509277
Bunn; Paul A. Patent Filings

Bunn; Paul A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bunn; Paul A..The latest application filed is for "methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients".

Company Profile
0.2.9
  • Bunn; Paul A. - Evergreen CO
  • Bunn; Paul A. - Denver CO US
  • Bunn; Paul A. - Steamboat Springs CO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Prediction Of Clinical Outcome To Epidermal Growth Factor Receptor Inhibitors By Cancer Patients
App 20170029901 - Garcia; Marileila Varella ;   et al.
2017-02-02
Flurbiprofen analogs and methods of use in treating cancer
Grant 8,575,170 - Gera , et al. November 5, 2
2013-11-05
Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
App 20120177641 - BUNN; Paul A. ;   et al.
2012-07-12
Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors
App 20120141479 - Witta; Samir E. ;   et al.
2012-06-07
Flurbiprofen Analogs And Methods Of Use In Treating Cancer
App 20110275648 - GERA; Lajos ;   et al.
2011-11-10
Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
App 20100196366 - Bunn; Paul A. ;   et al.
2010-08-05
Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors
App 20080234265 - Witta; Samir E. ;   et al.
2008-09-25
Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors
App 20080182865 - Witta; Samir E. ;   et al.
2008-07-31
Gefitinib Sensitivity-related Gene Expression And Products And Methods Related Thereto
App 20080113874 - BUNN; Paul A. ;   et al.
2008-05-15
Methods for Prediction of Clinical Outcome to Epidermal Growth Factor Receptor Inhibitors by Cancer Patients
App 20080090233 - Garcia; Marileila Varella ;   et al.
2008-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed